BrainsWay Stock (NASDAQ:BWAY)
Previous Close
$9.70
52W Range
$4.16 - $10.98
50D Avg
$9.16
200D Avg
$6.95
Market Cap
$169.82M
Avg Vol (3M)
$99.30K
Beta
0.37
Div Yield
-
BWAY Company Profile
Brainsway Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, Europe, Israel, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company primarily serves doctors, hospitals, and medical centers in the field of psychiatry. Brainsway Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel.
BWAY Performance
Peer Comparison
| Ticker | Company |
|---|---|
| AIMD | Ainos, Inc. |
| FNA | Paragon 28, Inc. |
| MDGS | Xylo Technologies Ltd. |
| OFIX | Orthofix Medical Inc. |
| LNSR | LENSAR, Inc. |
| DCTH | Delcath Systems, Inc. |
| VAPO | Vapotherm, Inc. |
| IRIX | IRIDEX Corporation |
| NPCE | NeuroPace, Inc. |
| SRDX | Surmodics, Inc. |
| KIDS | OrthoPediatrics Corp. |
| AZYO | Elutia Inc. |
| VERO | Venus Concept Inc. |
| AORT | Artivion, Inc. |
| TCMD | Tactile Systems Technology, Inc. |
| CVRX | CVRx, Inc. |